Dalan Biosciences
Athens, US · Founded 2018 · 3 known investors
Dalan develops vaccines that work with animals' natural immune defenses to protect against disease, with products including a USDA-approved honeybee vaccine and a shrimp vaccine in development. The company operates in the bioscience and animal health sector, serving agriculture and aquaculture markets.
Founders & leadership
Dalan Biosciences was founded in 2018 by Annette Kleiser.
AK
Annette KleiserFounder & CEO
Investors · 3
Reported raises · per SEC filings
Form D private placements$3.6M disclosed across 1 round · 2022
▶$3.6MraisedSep 2022 · 34 investors · AgricultureRule 506(b)
▶$3.6MraisedSep 2022 · 34 investors · Agriculture
Rule 506(b)Officers, directors & promoters on the filing
- Annette KleiserExecutive Officer, Director
- Offering amount
- $3.6M
- Amount sold
- $3.6M
- Minimum investment
- $10K
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Dalan Biosciences do?
- Dalan develops vaccines that work with animals' natural immune defenses to protect against disease, with products including a USDA-approved honeybee vaccine and a shrimp vaccine in development. The company operates in the bioscience and animal health sector, serving agriculture and aquaculture markets.
- Who founded Dalan Biosciences?
- Dalan Biosciences was founded by Annette Kleiser in 2018.
- Who are Dalan Biosciences's investors?
- Dalan Biosciences's investors include At One Ventures, Prime Movers Lab, Good Growth Capital.
- How much funding has Dalan Biosciences raised?
- Dalan Biosciences has disclosed $3.6M raised across 1 round.
- Where is Dalan Biosciences headquartered?
- Dalan Biosciences is headquartered in Athens, US.